These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
483 related articles for article (PubMed ID: 17275030)
21. [Effects of hMIP-1beta gene modification on in vivo tumorigenicity and vaccine efficacy of tumor cells]. Luo XL; Xie YA; Kuang ZP; Wu JN; Liang AM Zhonghua Zhong Liu Za Zhi; 2008 Feb; 30(2):97-102. PubMed ID: 18646689 [TBL] [Abstract][Full Text] [Related]
22. Macrophage-derived chemokine gene transfer results in tumor regression in murine lung carcinoma model through efficient induction of antitumor immunity. Guo J; Wang B; Zhang M; Chen T; Yu Y; Regulier E; Homann HE; Qin Z; Ju DW; Cao X Gene Ther; 2002 Jun; 9(12):793-803. PubMed ID: 12040461 [TBL] [Abstract][Full Text] [Related]
23. [Allogeneic dendritic cell vaccine pulsed with heat shocked tumor cell lysate can enhance antitumor immunity]. You J; Wang CL; Hao XS Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(39):2785-90. PubMed ID: 18167273 [TBL] [Abstract][Full Text] [Related]
24. alpha-fetoprotein and interleukin-18 gene-modified dendritic cells effectively stimulate specific type-1 CD4- and CD8-mediated T-Cell response from hepatocellular carcinoma patients in Vitro. Cao DY; Yang JY; Dou KF; Ma LY; Teng ZH Hum Immunol; 2007 May; 68(5):334-41. PubMed ID: 17462500 [TBL] [Abstract][Full Text] [Related]
25. Modification of CEA with both CRT and TAT PTD induces potent anti-tumor immune responses in RNA-pulsed DC vaccination. Kim SG; Park MY; Kim CH; Sohn HJ; Kim HS; Park JS; Kim HJ; Oh ST; Kim TG Vaccine; 2008 Nov; 26(50):6433-40. PubMed ID: 18812201 [TBL] [Abstract][Full Text] [Related]
26. Mode-of-action, efficacy, and safety of a homologous multi-epitope vaccine in a murine model for adjuvant treatment of renal cell carcinoma. Doehn C; Esser N; Pauels HG; Kiessig ST; Stelljes M; Grossmann A; Jocham D; Drevs J Eur Urol; 2009 Jul; 56(1):123-31. PubMed ID: 18550267 [TBL] [Abstract][Full Text] [Related]
27. [Specific immune against pancreatic cancer induced by dendritic cells pulsed with mutant K-ras peptide]. Yang B; He Y; Sun DL; Zou Y; Qin XH; Huang BH Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(28):1956-60. PubMed ID: 19062734 [TBL] [Abstract][Full Text] [Related]
28. Vaccination of dendritic cells loaded with interleukin-12-secreting cancer cells augments in vivo antitumor immunity: characteristics of syngeneic and allogeneic antigen-presenting cell cancer hybrid cells. Suzuki T; Fukuhara T; Tanaka M; Nakamura A; Akiyama K; Sakakibara T; Koinuma D; Kikuchi T; Tazawa R; Maemondo M; Hagiwara K; Saijo Y; Nukiwa T Clin Cancer Res; 2005 Jan; 11(1):58-66. PubMed ID: 15671528 [TBL] [Abstract][Full Text] [Related]
29. [Treatment of spontaneous metastatic lung cancer with tumor antigen-pulsed, interleukin-18 gene-modified dendritic cells]. Chen J; Cao X; Xiu Q Zhonghua Yi Xue Za Zhi; 2001 Jul; 81(13):779-82. PubMed ID: 11798964 [TBL] [Abstract][Full Text] [Related]
30. Dendritic cells pulsed or fused with AML cellular antigen provide comparable in vivo antitumor protective responses. Weigel BJ; Panoskaltsis-Mortari A; Diers M; Garcia M; Lees C; Krieg AM; Chen W; Blazar BR Exp Hematol; 2006 Oct; 34(10):1403-12. PubMed ID: 16982333 [TBL] [Abstract][Full Text] [Related]
32. Modification of dendritic cells with interferon-gamma-inducible protein-10 gene to enhance vaccine potency. Kang TH; Bae HC; Kim SH; Seo SH; Son SW; Choi EY; Seong SY; Kim TW J Gene Med; 2009 Oct; 11(10):889-98. PubMed ID: 19618483 [TBL] [Abstract][Full Text] [Related]
33. [Inhibitory effect of dendritic cells pulsed with MAGE-3 peptide on transplanted murine gastric cancer in mice]. Lü B; Liu BY; Zhang Y; Chen XH; Zhu ZG; Yin HR; Lin YZ Zhonghua Yi Xue Za Zhi; 2005 Aug; 85(30):2120-3. PubMed ID: 16313822 [TBL] [Abstract][Full Text] [Related]
34. Induction of cytolytic T lymphocytes against pediatric solid tumors in vitro using autologous dendritic cells pulsed with necrotic primary tumor. Shilyansky J; Jacobs P; Doffek K; Sugg SL J Pediatr Surg; 2007 Jan; 42(1):54-61; discussion 61. PubMed ID: 17208541 [TBL] [Abstract][Full Text] [Related]
35. [Anti-metastatic effect of vascular endothelial growth factor receptor 2 extracellular domain gene-modified dendritic cell vaccination in murine model with experimental pulmonary metastasis]. Pan JP; Weng YS; Wu QQ Zhonghua Zhong Liu Za Zhi; 2006 Sep; 28(9):646-9. PubMed ID: 17274366 [TBL] [Abstract][Full Text] [Related]
36. Enhanced induction of anti-tumor immunity in human and mouse by dendritic cells pulsed with recombinant TAT fused human survivin protein. Cho HI; Kim EK; Park SY; Lee SK; Hong YK; Kim TG Cancer Lett; 2007 Dec; 258(2):189-98. PubMed ID: 17931768 [TBL] [Abstract][Full Text] [Related]
37. Adenovirus-mediated interleukin-18 mutant in vivo gene transfer inhibits tumor growth through the induction of T cell immunity and activation of natural killer cell cytotoxicity. Hwang KS; Cho WK; Yoo J; Seong YR; Kim BK; Kim S; Im DS Cancer Gene Ther; 2004 Jun; 11(6):397-407. PubMed ID: 15044962 [TBL] [Abstract][Full Text] [Related]
38. Tumor secreting high levels of IL-15 induces specific immunity to low immunogenic colon adenocarcinoma via CD8+ T cells. Araki A; Hazama S; Yoshimura K; Yoshino S; Iizuka N; Oka M Int J Mol Med; 2004 Oct; 14(4):571-6. PubMed ID: 15375583 [TBL] [Abstract][Full Text] [Related]
39. Dendritic cell vaccine therapy by immunization with fusion cells of interleukin-2 gene-transduced, spleen-derived dendritic cells and tumour cells. Ogawa F; Iinuma H; Okinaga K Scand J Immunol; 2004 May; 59(5):432-9. PubMed ID: 15140052 [TBL] [Abstract][Full Text] [Related]
40. Effective combination of chemotherapy and dendritic cell administration for the treatment of advanced-stage experimental breast cancer. Yu B; Kusmartsev S; Cheng F; Paolini M; Nefedova Y; Sotomayor E; Gabrilovich D Clin Cancer Res; 2003 Jan; 9(1):285-94. PubMed ID: 12538481 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]